Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer

ClinicalTrials.gov ID: NCT00040742

Public ClinicalTrials.gov record NCT00040742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II/III Randomized, Controlled Clinical Trial Of Ginger (Zingiber Officinale) For Nausea Caused By Chemotherapy For Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Ginger may help reduce or prevent nausea. It is not yet known if antiemetic drugs are more effective with or without ginger in treating nausea caused by chemotherapy. PURPOSE: This randomized phase II/III trial is studying giving antiemetic drugs together with ginger to see how well they work compared to antiemetic drugs alone in treating nausea in patients who are receiving chemotherapy for cancer.

Study identification

NCT ID
NCT00040742
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Gary Morrow
Other
Enrollment
745 participants

Conditions and interventions

Interventions

Dietary Supplement · Other

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2003 (Type not available)
Primary completion
Aug 2011 (Actual)
Completion
Dec 2011 (Actual)
Last update posted
Nov 9, 2015

2003 – 2011

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
MBCCOP - Gulf Coast Mobile Alabama 36606 —
MBCCOP - Hawaii Honolulu Hawaii 96813 —
MBCCOP - University of Illinois at Chicago Chicago Illinois 60612-7323 —
CCOP - Central Illinois Decatur Illinois 62526 —
CCOP - Wichita Wichita Kansas 67214-3882 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York 13057 —
CCOP - North Shore University Hospital Manhassett New York 11030 —
CCOP - Southeast Cancer Control Consortium Goldsboro North Carolina 27534-9479 —
CCOP - Columbus Columbus Ohio 43215 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
CCOP - Greenville Greenville South Carolina 29615 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
CCOP - Northwest Tacoma Washington 98405-0986 —
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00040742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2015 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00040742 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →